-
Stopping Lung Cancer Before It Starts with Drs. Steven Dubinett & Avrum Spira
- 2024/06/24
- 再生時間： 32 分
- ポッドキャスト
-
サマリー
activate_samplebutton_t1
あらすじ・解説
Episode Highlights
0:15 Intro
3:39 Update in pre-lung cancer genome atlas research
17:06 Next steps: applying innovations in bronchoscopy
21:45 When we can anticipate results
25:05 Understanding the lung’s microbiome
29:21 Utility of fragmentomics
31:01 Outro
Dr. Steven Dubinett at University of California, Los Angeles and Dr. Avrum Spira at Boston University revisit our virtual studio to provide an update on their lung cancer interception research, as currently funded by the American Lung Association and LUNGevity Foundation. With the goal of combating cancer at a preliminary stage, Drs. Dubinett and Spira are focused on refining molecular and imaging markers to help identify high-risk premalignant lesions. These findings hope to lead to future therapeutics halting the progression of cells likely to cause invasive cancer.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
0:15 Intro
3:39 Update in pre-lung cancer genome atlas research
17:06 Next steps: applying innovations in bronchoscopy
21:45 When we can anticipate results
25:05 Understanding the lung’s microbiome
29:21 Utility of fragmentomics
31:01 Outro
Dr. Steven Dubinett at University of California, Los Angeles and Dr. Avrum Spira at Boston University revisit our virtual studio to provide an update on their lung cancer interception research, as currently funded by the American Lung Association and LUNGevity Foundation. With the goal of combating cancer at a preliminary stage, Drs. Dubinett and Spira are focused on refining molecular and imaging markers to help identify high-risk premalignant lesions. These findings hope to lead to future therapeutics halting the progression of cells likely to cause invasive cancer.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast